Cross Linked Sodium Hyaluronate injection 3%

Osteoarthritis, the condition is frequently treated by intra-articular injection of Cross-Linked Sodium Hyaluronate 3% – GenuVida XL 3% as a single dose occurs naturally in high concentrations in joint cartilage and in joint fluid,
where it protects and lubricates the joint. GenuVida XL 3% replaces the Hyaluronic Acid that exists naturally in joint fluid and so acts as a painkiller and lubricant. GenuVida XL 3% is a cross-linked, non-surgical, nonpharmacologic therapy for Knee Osteoarthritis. Cross-Linking enhance the sustainability of GenuVida XL 3%.